Heart Diseases in Different Rationale

Although CVD has sometimes been considered a disease that predominantly affects men, it is the leading cause of death among both men and women globally. There are number of notable gender differences in CVD incidence, mortality, risk-factor profiles, outcomes, and clinical presentation. These differences remain consistent across populations and regions and are thus important to consider when developing CVD prevention and treatment programs.

PregnancyThe evaluation of individuals with valvular heart disease who are or wish to become pregnant is a difficult issue. Issues that have to be addressed include the risks during pregnancy to the mother and the developing fetus by the presence of maternal valvular heart disease as an intercurrent disease in pregnancy. Normal physiological changes during pregnancy require, on average, a 50% increase in circulating blood volume that is accompanied by an increase in cardiac output that usually peaks between the mid portion of the second and third trimesters The increased cardiac output is due to an increase in the stroke volume, and a small increase in heart rate, averaging 10 to 20 beats per minute. Additionally uterine circulation and endogenous hormones cause systemic vascular resistance to decrease and a disproportionately lowering of diastolic blood pressure causes a wide pulse pressure.

Physiological changes during pregnancy and puerperium

Pregnancy and valvular heart disease

Pregnancy and congenital heart disease

Pregnancy and cardiomyopathy

Women: There are many misconceptions about CVDs in women. In reality, CVDs affect as many men as women. However, women loose less years of life due to CVDs as the disease develops about 7-10 years later in women compared to men.

Gender norms and roles influence these risk factors as women, in some contexts, do not have access to and control over resources that can diminish their exposure to the risk factors.

The risk of heart disease and stroke in women are often underestimated because of the mistaken notion that females are protected from CVDs. There may be certain differences in the clinical presentation of CVD in women leading to inadequate diagnostic and treatment interventions

Pediatricsis responsible for the diagnosis of congenital heart defects, performing diagnostic procedures such as echocardiograms, cardiac catheterizations, and for the on going   management of the sequel of heart disease in infants, children and adolescents. The division is actively involved in research aimed at preventing both congenital and acquired heart disease in children. Finally, the division is committed to educating the next generation of physicians, and offers advanced training in paediatric cardiology.

  • Pregnancy
  • Women
  • Paediatrics

Related Conference of Heart Diseases in Different Rationale

June 26-28, 2017

9th Annual European Pharma Congress

Madrid, Spain
July 06-07, 2017

8th Global Pharmacovigilance & Drug Safety Summit

Kuala Lumpur, Malaysia
July 17-18, 2017

9th World Congress on BA/BE Studies and Biowaivers

Melbourne, Australia
July 24-25, 2017

8th World Congress on Pharmacology and Toxicology

Melbourne, Australia
July 31-Aug 02, 2017

7th Global Experts Meeting on Neuropharmacology

Milan, Italy
July 31-August 01, 2017

Analytical and Bio-Analytical Techniques Congress

Melbourne, Australia
August 07-09, 2017

4th World Congress on Chromatography

Rome, Italy
August 31-September 01, 2017,

3rd International Conference on Biopharmaceutics and Biologic Drugs

Philadelphia, USA
(10 Plenary Forums - 1Event)
August 31-September 01, 2017

5th International Pharmacy Conference


(10 Plenary Forums - 1 Event)
Philadelphia, USA
September 04-06, 2017

9th World Congress on Pharmacology

Paris, France
September 11-13, 2017

4th International Conference on Clinical Trials

San Antonio, Texas, USA
(10 Plenary Forums - 1 Event)
September 11-12, 2017

World Congress on Biotherapeutics and Bioanalytical Techniques

(10 Plenary Forums - 1Event) Dallas, Texas, USA
September 18-19, 2017

6th International Conference on Forensic Research & Technology

(10 Plenary Forums - 1Event)
Houston, Texas, USA
Sep 25-26, 2017

12th Annual
Pharma Middle East Congress

Dubai, UAE
October 02-03, 2017

9th Annual Pharmaceutical Chemical Analysis Congress

Vienna, Austria
October 09-11, 2017

Global Experts Meeting on Case Reports

Osaka, Japan
October 16-17, 2017

16th Annual Medicinal & Pharmaceutical Sciences Congress

Seoul, South Korea
October 16-18, 2017
(10 Plenary Forums - 1 Event)

4th International Conference on Past and Present Research Systems of Green Chemistry

Atlanta, Georgia, USA
October 18-19, 2017

6th Global Congress on Mass Spectrometry

Osaka, Japan
October 19-20, 2017

9th Annual Congress on Drug Design & Drug Formulation

Seoul, South Korea
October 19-20, 2017

4th International Conference and Exhibition on Pain Medicine

(10 Plenary Forums - 1 Event)
San Francisco, California, USA
(10 Plenary Forums - 1 Event) October 23-24, 2017

5th International Conference on Clinical Pharmacy and Healthcare IT

Orlando, Florida, USA
October 30-November 01, 2017
A B2B Networking & Global Knowledge Exchange Forum

Annual Congress on Emerging Orphan Drugs and  Rare Diseases

San Antonio, Texas, USA
November 13-14, 2017

Global Experts Meeting on Toxicology

Singapore
November 23-24, 2017

Annual Meeting on Pharmacology

Dubai, UAE
Mar 19-20, 2018

International Meeting on Nutraceuticals

Singapore
April 26-27, 2018

11th European Biosimilars Congress

Rome, Italy
July 16-18, 2018

15th Asia-Pacific Pharma Congress

Melbourne, Australia
March 28-29, 2018

11th Annual Congress on Pharmacovigilance and Clinical Trials

Orlando, Florida, USA

Heart Diseases in Different Rationale Conference Speakers

Recommended Sessions

Related Journals

Are you interested in